Most Popular
-
1
1 in 3 Koreans live alone, family types becoming diverse
-
2
Korea, Japan finance chiefs vow to tame rampant FX market volatility
-
3
K-pop group's manager dismissed for setting up spycam in theater dressing room
-
4
Contentious grain bill put directly to plenary meeting for vote
-
5
Why is Apple Pay struggling to get purchase in Korea?
-
6
Trilateral talks acknowledge ‘serious’ slumps of won, yen
-
7
Will tug-of-war between doctors, government end soon?
-
8
Climate impacts set to cut 2050 global GDP by nearly a fifth
-
9
[Today’s K-pop] BTS pop-up event to come to Seoul
![[Today’s K-pop] BTS pop-up event to come to Seoul](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050734_0.jpg&u=)
-
10
[Graphic News] More Koreans say they plan long-distance trips this year
![[Graphic News] More Koreans say they plan long-distance trips this year](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050828_0.gif&u=)
![[Today’s K-pop] BTS pop-up event to come to Seoul](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050734_0.jpg&u=)
![[Graphic News] More Koreans say they plan long-distance trips this year](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050828_0.gif&u=)
Medytox says China approvals proceeding without glitch
By Lim Jeong-yeoPublished : June 5, 2019 - 17:31
Government approval for wrinkle-smoothening botulinum toxin Medytoxin is proceeding as planned in China under the name Neuronox, Korean BTX maker Medytox said Wednesday in a regulatory filing.
It came in response to a local media report that claimed the China Food and Drug Administration has ceased its review of Neuronox.
It came in response to a local media report that claimed the China Food and Drug Administration has ceased its review of Neuronox.
On Wednesday, shares of Medytox shares closed at 435,000 won ($370), down 7.76 percent from a day earlier.
Medytox said the Neuronox is in the final stage of the approval process, and it has not been notified of any cessation of review.
Medytox had applied for sales approval of Neuronox in China in February 2018.
By Lim Jeong-yeo (kaylalim@heraldcorp.com)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
